SPRO Annual Shareholders Equity
$106.89 M
+$30.96 M+40.77%
31 December 2023
Summary:
As of January 23, 2025, SPRO annual stockholders equity is $106.89 million, with the most recent change of +$30.96 million (+40.77%) on December 31, 2023. During the last 3 years, it has fallen by -$25.15 million (-19.04%). SPRO annual shareholders equity is now -19.04% below its all-time high of $132.04 million, reached on December 31, 2020.SPRO Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPRO Quarterly Shareholders Equity
$65.51 M
-$14.99 M-18.62%
30 September 2024
Summary:
As of January 23, 2025, SPRO quarterly stockholders equity is $65.51 million, with the most recent change of -$14.99 million (-18.62%) on September 30, 2024. Over the past year, it has dropped by -$41.39 million (-38.72%). SPRO quarterly shareholders equity is now -50.67% below its all-time high of $132.79 million, reached on September 30, 2020.SPRO Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SPRO Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +40.8% | -38.7% |
| 3 y3 years | -19.0% | -38.7% |
| 5 y5 years | -7.5% | -38.7% |
SPRO Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +40.8% | -38.7% | +101.7% |
| 5 y | 5-year | -19.0% | +43.3% | -50.7% | +101.7% |
| alltime | all time | -19.0% | >+9999.0% | -50.7% | +544.2% |
Spero Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $65.51 M(-18.6%) |
| June 2024 | - | $80.50 M(-16.4%) |
| Mar 2024 | - | $96.25 M(-10.0%) |
| Dec 2023 | $106.89 M(+40.8%) | $106.89 M(+99.0%) |
| Sept 2023 | - | $53.70 M(-2.0%) |
| June 2023 | - | $54.78 M(-15.5%) |
| Mar 2023 | - | $64.84 M(-14.6%) |
| Dec 2022 | $75.93 M(-14.0%) | $75.93 M(+133.8%) |
| Sept 2022 | - | $32.48 M(-9.6%) |
| June 2022 | - | $35.92 M(-42.5%) |
| Mar 2022 | - | $62.47 M(-29.2%) |
| Dec 2021 | $88.29 M(-33.1%) | $88.29 M(-21.1%) |
| Sept 2021 | - | $111.89 M(+24.0%) |
| June 2021 | - | $90.25 M(-24.1%) |
| Mar 2021 | - | $118.85 M(-10.0%) |
| Dec 2020 | $132.04 M | $132.04 M(-0.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2020 | - | $132.79 M(+80.1%) |
| June 2020 | - | $73.71 M(-10.6%) |
| Mar 2020 | - | $82.43 M(+10.5%) |
| Dec 2019 | $74.57 M(-35.4%) | $74.57 M(-19.5%) |
| Sept 2019 | - | $92.68 M(-15.2%) |
| June 2019 | - | $109.31 M(-3.2%) |
| Mar 2019 | - | $112.97 M(-2.2%) |
| Dec 2018 | $115.50 M(+36.5%) | $115.50 M(-7.7%) |
| Sept 2018 | - | $125.20 M(+91.7%) |
| June 2018 | - | $65.31 M(-12.4%) |
| Mar 2018 | - | $74.54 M(-11.9%) |
| Dec 2017 | $84.60 M(+732.0%) | $84.60 M(+253.7%) |
| Sept 2017 | - | $23.92 M(-24.8%) |
| June 2017 | - | $31.78 M(+212.5%) |
| Dec 2016 | $10.17 M(+5088.3%) | $10.17 M |
| Dec 2015 | $196.00 K | - |
FAQ
- What is Spero Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for Spero Therapeutics?
- What is Spero Therapeutics annual shareholders equity year-on-year change?
- What is Spero Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Spero Therapeutics?
- What is Spero Therapeutics quarterly shareholders equity year-on-year change?
What is Spero Therapeutics annual stockholders equity?
The current annual shareholders equity of SPRO is $106.89 M
What is the all time high annual shareholders equity for Spero Therapeutics?
Spero Therapeutics all-time high annual stockholders equity is $132.04 M
What is Spero Therapeutics annual shareholders equity year-on-year change?
Over the past year, SPRO annual stockholders equity has changed by +$30.96 M (+40.77%)
What is Spero Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of SPRO is $65.51 M
What is the all time high quarterly shareholders equity for Spero Therapeutics?
Spero Therapeutics all-time high quarterly stockholders equity is $132.79 M
What is Spero Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, SPRO quarterly stockholders equity has changed by -$41.39 M (-38.72%)